EUVIMEDEUVIMED entdecken
Crossref

Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration

Yang Wu, Zheqi Li, Adrian V Lee, Steffi Oesterreich, Bin Luo

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07255-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Yang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Estrogen Receptor alpha, Mutation, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Initiative Scientific Research Program, Institute for Intelligent Healthcare, Tsinghua University, The Breasties.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Hotspot estrogen receptor alpha (ER/ESR1) mutations are recognized as the driver for both endocrine resistance and metastasis in advanced ER-positive (ER+) breast cancer, but their contributions to metastatic organ tropism remain insufficiently understood. In this study, we aim to comprehensively profile the organotropic metastatic pattern for ESR1 mutant breast cancer. METHODS: The organ-specific metastatic pattern of ESR1 mutant breast cancer was delineated using multi-omics data from multiple publicly available cohorts of ER+ metastatic breast cancer patients. Gene mutation/copy number variation (CNV) and differential gene expression analyses were performed to identify the genomic and transcriptomic alterations uniquely associated with ESR1 mutant liver metastasis. Upstream regulator, downstream pathway, and immune infiltration analysis were conducted for subsequent mechanistic investigations. RESULTS: ESR1 mutation-driven liver tropism was revealed by significant differences, encompassing a higher prevalence of liver metastasis in patients with ESR1 mutant breast cancer and an enrichment of mutations in liver metastatic samples. The significant enrichment of AGO2 copy number amplifications (CNAs) and multiple gene expression changes were revealed uniquely in ESR1 mutant liver metastasis. We also unveiled alterations in downstream signaling pathways and immune infiltration, particularly an enrichment of neutrophils, suggesting potential therapeutic vulnerabilities. CONCLUSION: Our data provide a comprehensive characterization of the behaviors and mechanisms of ESR1 mutant liver metastasis, paving the way for the development of personalized therapy to target liver metastasis for patients with ESR1 mutant breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEstrogen Receptor alphaMutationLiver NeoplasmsHumansFemaleGene Expression Regulation, NeoplasticDNA Copy Number VariationsGene Expression ProfilingBiomarkers, TumorLiverTranscriptome

Stichwörter der Autor:innen

ER mutationImmune filtrationLiver tropismMetastatic breast cancerMolecular changes

Substanzen

Estrogen Receptor alphaBiomarkers, TumorESR1 protein, human

Autor:innen und Institutionen

  • School of Medicine, Tsinghua University, Beijing, China.
  • Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of General Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, China. luobin@mail.tsinghua.edu.cn.

Förderung

  • Initiative Scientific Research Program, Institute for Intelligent Healthcare, Tsinghua University
  • The Breasties

Zitieren

APA

Wu, Y., Li, Z., Lee, A. V., Oesterreich, S., & Luo, B. (2024). Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07255-4

Vancouver

Wu Y, Li Z, Lee AV, Oesterreich S, Luo B. Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07255-4

BibTeX
@article{Wu2024,
  author = {Wu, Yang and Li, Zheqi and Lee, Adrian V and Oesterreich, Steffi and Luo, Bin},
  title = {Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07255-4}
}
Kostenlos starten →